Insmed (INSM) PT Lowered to $195 at RBC Capital

June 5, 2026 5:42 AM

RBC Capital analyst Leonid Timashev lowered the price target on Insmed (NASDAQ: INSM) to $195.00 (from $205.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found